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Otitis media with effusion (OME) is the most common cause of hearing loss in children and tympanostomy to
alleviate the condition remains the commonest surgical intervention in children in the developed world.
Chronic and recurrent forms of OM are known to have a very significant genetic component, however,
until recently little was known of the underlying genes involved. The identification of mouse models of chron-
ic OM has indicated a role of transforming growth factor beta (TGFb) signalling and its impact on responses
to hypoxia in the inflamed middle ear. We have, therefore, investigated the role of TGFb signalling and iden-
tified and characterized a new model of chronic OM carrying a mutation in the gene for transforming growth
interacting factor 1 (Tgif1). Tgif1 homozygous mutant mice have significantly raised auditory thresholds due
to a conductive deafness arising from a chronic effusion starting at around 3 weeks of age. The OM is accom-
panied by a significant thickening of the middle ear mucosa lining, expansion of mucin-secreting goblet cell
populations and raised levels of vascular endothelial growth factor, TNF-a and IL-1b in ear fluids. We also
identified downstream effects on TGFb signalling in middle ear epithelia at the time of development of chron-
ic OM. Both phosphorylated SMAD2 and p21 levels were lowered in the homozygous mutant, demonstrating a
suppression of the TGFb pathway. The identification and characterization of the Tgifmutant supports the role
of TGFb signalling in the development of chronic OM and provides an important candidate gene for genetic
studies in the human population.
INTRODUCTION
Otitis media with effusion (OME), inflammation of the middle
ear, is the commonest cause of hearing impairment in children
and the commonest reason for surgery in children. Both
chronic and recurrent forms of OM are known to have a sig-
nificant genetic component (1,2), but until recently little was
known about the genes or pathways involved (3,4). Several
mouse models of OM have been reported and some of them,
including the mutants Jeff and Junbo, implicate the transform-
ing growth factor beta (TGFb) signalling pathway in suscepti-
bility to OM (5–7). Both mutants were identified from a
deafness screen as part of a large-scale phenotype-driven
mouse ENU mutagenesis programme (8). Mice heterozygous
for the Jeff mutation develop chronic proliferative OM (9)
and the gene mutated in Jeff was identified as Fbxo11 (5).
We found that Fbxo11 is involved in the regulation of the
TGFb signalling pathway by regulating the levels of
pSmad2 in the epithelial cells of different embryonic mouse
tissues. Furthermore, we identified a genetic interaction
between Fbxo11 and Smad2 (7). Junbo mice display chronic
suppurative OM and carry a mutation in the transcription
factor Evi1 (6). Evi1 can repress the TGFb signalling
pathway by interacting with Smad3 and can antagonize the
growth-inhibitory effect of the pathway (10). The identifica-
tion of these mutants has focussed studies on the role of
TGFb signalling in the development of chronic OM and the
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interaction of this pathway with other molecular and cellular
changes occurring in the inflamed middle ear (11).
The TGFb signalling pathway is involved in a variety of
cellular processes such as proliferation, differentiation and
apoptosis (12,13). TGFb pathway members act by linking
membrane receptors to specific target genes. TGFb ligands
initiate the signalling by binding to a type II receptor on the
cell surface that in turn binds and phosphorylates a type I re-
ceptor. The intracellular mediators, R-Smads, Smad2 and
Smad3, become phosphorylated by the TGFb receptor I. The
activated Smads form a complex with the co-mediator
Smad4. The Smad complex then translocates into the
nucleus and in conjunction with other nuclear cofactors regu-
lates the transcription of different target genes (12). The phos-
phorylation of the R-Smads is regulated by the Smad anchor
for receptor activation (SARA) protein, cytoplasmic promye-
locytic leukaemia (cPML) protein and transforming growth
interacting factor (TGIF). SARA has a Smad binding
domain and a domain interacting with the TGFb receptor
and recruits Smad2 and/or Smad3 to the receptor (14). In
the cytoplasm, cPML physically interacts with Smad2/3 and
SARA and is required for the association of Smad2/3 with
SARA (15).
TGIF1, also known as TGIF, belongs to a three amino acid
loop extension (TALE) subgroup of atypical homeodomain
proteins (16,17). It has been found that TGIF functions
through several routes as a negative regulator of the TGFb sig-
nalling pathway. TGIF was initially identified as a Smad2-
binding protein and a co-repressor of TGFb-induced transcrip-
tion. This repression is mediated by the ability of TGIF to
recruit to Smad2 a co-repressor containing histone deacety-
lases (HDACs) (18). TGIF can also inhibit Smad2 phosphoryl-
ation by an alternative mechanism to its association with
Smad2, acting in partnership with c-Jun to sequester cPML
in the nucleus. This prevents the formation of the
cPML-SARA complex that is required for the phosphorylation
of Smad2 (19). In addition, TGIF can restrict TGFb signalling
by recruiting TGIF-interacting ubiquitin ligase 1-
WW-containing protein. Tiul1 is an E3 ubiquitin ligase that
interacts with TGIF to induce the degradation of Smad2
(20). Recently, PML competitor for TGIF association
(PCTA) has been found to compete with cPML for binding
to TGIF, resulting in the accumulation of cPML in the cyto-
plasm and inducing the phosphorylation of R-Smads by the
TGFb type I receptor. PCTA can reverse the inhibitory activ-
ity of TGIF (21,22). TGIF2 is also a member of the TALE sub-
class of homeobox proteins and shows distinct homology with
TGIF1, especially in its DNA-binding domain (23). It was
reported that TGIF2 can perform many of the same functions
as TGIF1 (24). Similarly to TGIF1, TGIF2 binds to Smad
and HDAC, acting as a repressor in the TGFb signalling
pathway (24).
Human TGIF1 maps to 18p11.3 (25). This chromosomal
region contains a locus associated with holoprosencephaly
(HPE), a common developmental defect affecting the fore-
brain and the face (26). Mutations in the human TGIF1 gene
have been associated with HPE (27), but Tgif1 knockout
mice on a mixed background were reported to be indistin-
guishable from wild-type mice possibly due to a functional re-
dundancy with Tgif2 (28,29). Recently, it has been
demonstrated that the Tgif1 mutation in mice can cause HPE
when combined with a mutation in the closely related Tgif2
gene (30). In humans, TGIF1 was found to be highly
expressed in adult tissues such as placenta, liver, kidney, pros-
tate, ovary and testis (16). Mouse Tgif1 was found to be widely
expressed in the E9.5 embryo, with the highest expression in
the forebrain, the branchial arches, the otic pit and the limb
buds (28). It was also detected at E10.5 and E12.5 in the ven-
tricular neuroepithelium. The expression was found to decline
by E14.5 (28).
Given the role of TGIF as a regulator of the TGFb signal-
ling pathway, we decided to investigate whether Tgif knockout
mice display a similar phenotype to Jeff and Junbo mice. We
report here the Tgif mutant mouse as a novel model of OM.
Tgif mutants exhibit auditory deficits due to the development
of OM by weaning age. Our findings further elaborate the
role of the TGFb pathway in genetic predisposition to OM.
RESULTS
A targeted knockout of Tgif1 was used to examine potential
auditory phenotypes associated with the gene, including OM.
Tgif mutant mice had originally been generated and main-
tained on a mixed background and were reported to be
viable, fertile and with no obvious phenotype in the major
organ systems (28). We maintained the colony on a C57BL/
6J background by recurrent backcrossing. To generate mice
homozygous for Tgif, heterozygous animals were intercrossed
and the progeny were genotyped by PCR assay as previously
described (28). The surviving homozygotes at weaning age
comprised 10.84% (31 of 286) of the mice from this cross
that was less than the expected 25% (x2 ¼ 0.999857458,
df1, P ¼ 0.000000032).
To produce additional homozygous mice for this study, we
crossed heterozygote Tgif females with Tgif/Tgif males. The
surviving homozygotes at weaning age were 27.86% (39 of
140) that was less than the expected 50% (x2 ¼
0.999680234, df1, P ¼ 0.00000016). About 50% of the homo-
zygous mice from both crosses were missing by weaning
(postnatal day 21, P21), suggesting embryonic or neonatal le-
thality (Table 1). Some of the mutant mice (4 of 199 heterozy-
gotes and 11 of 67 homozygotes) developed hydrocephalus at
the age of 1 month, which may be one of the reasons why
some of the mutant mice do not survive (Fig. 1A). No wild-
type littermate mice (0 of 68) in this study developed hydro-
cephalus, in line with the low (0.029%) spontaneous rate of
this condition in the background C57BL/6J strain (http://
jaxmice.jax.org/jaxnotes/archive/490f.html). We also set up a
number of homozygote intercrosses. Out of five plugged
females, only one (20%) gave birth to seven pups, suggesting
that the null mothers may have a placental defect and lose their
embryos before birth (Table 1).
Placental defects in Tgif null mothers
Because of the low number of pups born from homozygote
intercrosses, we searched for defects in the placenta of the
Tgif mutants. It has been described previously that Tgif null
mice (29) on a relatively pure C57BL/6J background have
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severe placental defects, primarily due to absence of TGIF
function in the mother (31). We studied the placental pheno-
type of the mice from homozygote intercrosses at E9.5,
11.5, 13.5, 15.5 and 18.5. At E9.5 and 11.5, out of eight
embryos from each litter, seven looked normal and only one
was resorbed (Table 1). By E13.5, the number of the resorbed
embryos had increased and the number of embryos scored as
normal decreased. Out of 16 embryos from 2 litters, only 9
(56.25%) appeared normal, and we, therefore, proceeded to
study the homozygote placental phenotype at E13.5 and
compare it with the phenotype of the placenta from heterozy-
gote and wild-type mothers. In scoring, 93.33 and 81.48% of
the embryos from wild-type or heterozygous females, respect-
ively, were scored as normal which was higher than that
observed for homozygous females at this stage (73.68%);
however, this did not achieve statistical significance (P ¼
0.3299 2 × 3 Fisher’s exact test) (Table 1). We examined pla-
centas from heterozygous embryos for each maternal genotype
at E13.5. We did not detect a size difference in the placentas
from mice with different genotypes (Fig. 1B), but after sec-
tioning and staining with haematoxylin and eosin (H&E), we
observed a placental phenotype similar to that previously
described for Tgif null mice on a similar background to our
mice (31). For both heterozygous and homozygous mutants,
the central regions of the placental labyrinths were less well
developed. There was a reduction in maternal blood spaces
in mutant placentas, and the maternal blood spaces appeared
larger when compared with wild types with fewer surrounding
fetal vessels (Fig. 1C).
Craniofacial phenotype in Tgif mice
Tgif homozygous mice are smaller and appeared to have a
shorter face when compared with their wild-type littermates
(Fig. 2A). To investigate the craniofacial phenotype of the
mice, we took dorsoventral X-ray images of the skulls and
measured the length of the nasal bone. These measurements
were expressed relative to the full length of the skull to nor-
malize for differences in body size (Fig. 2B, C and D). Al-
though the results showed a significant difference between
homozygous Tgif mice and wild-type mice (P ¼ 0.000436),
no significant difference between the heterozygous Tgif mice
and wild-type mice was observed (P ¼ 0.5617), and the mag-
nitude of the difference between homozygotes and wild types
was small (,2%).
To investigate orientation and morphology of the Eusta-
chian tube (ET) in mutant mice compared with wild type,
the skulls were stained and the angle between the midline of
the skull and the bony part of the left and the right ETs was
measured (Fig. 2F and G). We did not detect statistically sig-
nificant differences in ET measurements between Tgif homo-
zygotes (n ¼ 3) and wild-type mice (n ¼ 5). In addition, we
measured the length and width of the bony part of the ET
(Fig. 2E and G). The mean length in wild-type mice (n ¼ 4)
was 1.03 mm, when compared with 1.14 mm in mutant homo-
zygotes (n ¼ 4), and mean width for wild-type mice was
1.43 mm, when compared with 1.46 mm in the homozygous
mutant. These differences were not statistically significant.
Hearing deficiency in Tgif mutants
We proceeded to assess auditory function in Tgif mutant mice.
A clickbox, that generates a brief 20 kHz soundburst at 90 dB
sound pressure levels (SPL), was used initially to assess the
hearing ability of mice through the presence or absence of a
Preyer’s reflex (32). When 1 month old, most of the Tgif
homozygote mice (86%, n ¼ 14) showed a reduced Preyer’s
reflex. When 2 months old, all the homozygote mice demon-
strated reduced hearing, but to a variable degree. Five mice
(36%, n ¼ 14) were scored deaf by clickbox as they did not
display a Preyer’s reflex, seven mice (50%, n ¼ 14) had
reduced hearing and two mice (14%, n ¼ 14) had almost
normal hearing, but were still assessed as reduced when com-
pared with wild-type mice. At the same age, heterozygous
mice had normal or slightly reduced hearing. Three of them
(27%, n ¼ 11) had reduced hearing and eight mice (73%,
n ¼ 11) had normal hearing. By comparison, 10 wild-type
mice all had normal hearing by clickbox.
An auditory-evoked brainstem response (ABR) test was
used to assess hearing thresholds in mutant mice (32). We
tested 14 homozygous, 11 heterozygous and 10 wild-type
mice at the age of 2 months for ABR response at 4 frequencies
8, 12, 20 and 26 kHz. We showed that the average ABR
thresholds were elevated by about 30 dB SPL in homozygotes
Table 1. Genotyping data from Tgif mutant crosses
M × F Stage Wt Het Hom Total/% alive Resorbed/found dead Total Litters
hom × hom E9.5 7 7 of 87.5% 1 8 1
hom × hom E11.5 7 7 of 87.5% 1 8 1
hom × hom E13.5 9 9 of 56.25% 7 16 2
hom × hom E15.5 5 5 0 5 1
hom × hom E18.5 5 5 0 5 1
hom × het E13.5 5 9 14 of 73.68% 5 19 2
het × het E13.5 5 8 9 22 of 81.48% 5 27 3
wt × het E13.5 6 8 14 of 93.33% 1 15 2
hom × hom P21 7 7 2 9 5
het × hom P21 77 39 140 of 80.92% 33 173 23
het × het P21 68 133 31 286 of 84.86% 51 337 41
The genotype of the mother (M) and the father (F) are indicated in the table. The number of the embryos and mice were analysed at different embryonic days
(E) and at weaning age, postnatal day 21 (P21).
Human Molecular Genetics, 2013, Vol. 22, No. 13 2555









and by about 20 dB SPL in heterozygotes, when compared
with wild-type mice, suggesting a conductive hearing loss
(Fig. 3). At all four frequencies, the ABR thresholds of the
homozygote mice were significantly different from the wild
types (at 8 kHz P ¼ 0.000447; 12 kHz P ¼ 0.003297;
20 kHz P ¼ 0.000486; 26 kHz P ¼ 0.004445). Significant dif-
ferences were also seen between heterozygotes and wild types
at two frequencies (8 kHz P ¼ 0.003229 and 20 kHz P ¼
0.023927).
We assessed whether there was a sensorineural element to
the hearing loss by dissecting inner ears from two 1-month-old
homozygous, heterozygous and wild-type mice to examine the
structure of the organ of Corti and the sensory cells. We did
not detect any abnormalities in the inner hair cell (IHC) or
outer hair cell (OHC) stereocilia bundles. Scanning electron
micrographs showed normal cell and bundle morphology in
the mid (Fig. 4A), apical and basal (data not shown) turns of
the cochlea in both mutants and wild types. In all the
samples, we could see well-organized rows of OHCs in the
organ of Corti and normal-sized IHCs. The histological exam-
ination of sagittal sections from the cochlea of 2-month-old
mice also confirms that there were no obvious abnormalities
in the cochlea or organ of Corti of homozygote Tgif mice.
We also observed no loss of spiral ganglion neurons (Fig. 4B).
Tgif mice display OM by 21 days after birth (DAB)
Five-, thirteen- and twenty-one-day old as well as 1-, 2- and
4-month-old adult heads were sectioned to investigate the
middle ear phenotype. Five- and thirteen-day-old Tgif/Tgif
middle ears were indistinguishable from wild types
(Fig. 5A–D). However, we detected an OM phenotype in
the middle ear of homozygote mice at 3 weeks. At that time
point, most of the homozygote mice (67%, n ¼ 6) had fluid
in the middle ear cavity and a thickened epithelial lining in
comparison with wild-type (n ¼ 16) controls. There was
only one wild type that demonstrated some fluid in the ear.
The ear effusions were cellular, with the presence of poly-
morphonuclear cells (PMNs) that are the first responding in-
flammatory cells that migrate towards the site of
inflammation (Fig. 5E–H). By comparison, three of the het-
erozygote mice at 21 days of age had fluid in one ear and
thickened lining (19%, n ¼ 16), and some of them had a thick-
ened epithelial lining only (37%, n ¼ 16) (Supplementary
Material, Fig. S1).
At 1 month, four homozygote mice had fluid in one ear
(37%, n ¼ 11) and only two had some fluid in both ears
(18%, n ¼ 11). Five mice did not have any fluid, but some
of these had a thickened epithelial lining (27% of mice). Sur-
prisingly, the effusions at 1 month did not appear cellular
(Fig. 5I–L). Two of the heterozygote mice had ear fluid and
a thickened lining (16%, n ¼ 13) and five had only a thickened
lining (38%, n ¼ 13). None of the wild type mice had OM at
this stage (n ¼ 7).
In 2-month-old homozygote ears, the inflammation had pro-
gressed to a chronic inflammation with effusion, as evidenced
by fluid in the middle ear cavity along with a thickened epithe-
lial lining. The effusion content was variable. In some of the
Figure 1. Hydrocephalus and placental defect in Tgif mutant mice. (A) One-month-old Tgif/Tgif homozygous mutant mouse with hydrocephalus (indicated with
an arrow). (B). Placentas from wild-type and mutant E13.5 embryos. No differences in size or morphology were observed. (C). Representative images of H&E
stained sections through the centre of the placenta for each genotype combination. Eight M+/+E+/2, 10 M+/2 E+/2 and 9 M2/2 E+/2 placentas were
analysed. Arrows and arrowheads indicate fetal and maternal blood spaces. The genotype of the mother (M) and the embryo (E) are indicated in the pictures and
the sections.
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homozygote mice, the middle ear fluid was more liquid and in
some thickened, more viscous (Fig. 5M, N, Q and R). At 2
months, five homozygote mice (42%, n ¼ 12) had unilateral
OM, five (42%, n ¼ 12) in both ears in each case associated
with thickening of the mucoperiosteum. Two homozygotes
(17%, n ¼ 12) did not have effusions, nor thickened epithelial
lining. Both of these mice showed relatively normal ABR
thresholds. By comparison, two of the heterozygote mice
had ear fluid (20%, n ¼ 10) and three had their epithelial
lining thickened (30%, n ¼ 10). Heterozygotes with ear fluid
and heterozygotes with thickened lining had elevated ABR
thresholds. None of the wild-type mice (n ¼ 7) had OM. In
homozygotes, the effusion was again cellular, and staining
with F4/80 antibody confirmed the presence of macrophages
in the ear fluid at this stage (Fig. 5O). We also studied the
OM phenotype of 4-month-old homozygote mice and
observed that six of them (60%, n ¼ 10) had unilateral OM,
two (20%, n ¼ 10) had effusion in both ears and two (20%,
n ¼ 10) did not have any fluid in the ears. Three of the
Tgif/+ mice had fluid in the ears and thickened lining (25%,
n ¼ 12) and three had thickened lining only (25%, n ¼ 12).
At both 2 and 4 months of age, we observed the appearance
of cellular debris-like aggregates in the ear effusions of the
homozygote (Fig. 5P, W). In addition, at 4 months we
observed polyps arising from the middle ear mucosa of the
homozygote mice (Fig. 5V). The wild-type mice (n ¼ 10) at
this stage did not display OM.
To quantify themucosal thickness of themiddle ears at differ-
ent stages, we examined the histological sections and took mea-
surements at five equidistant points along a 1 mm length of the
mucosa. Four to five homozygous and wild-typemice were ana-
lysed at each stage. There were significant differences between
mutant and wild type in the thickness of the epithelial lining at
each time point [21 days after birth (DAB) P ¼ 0.004713728; 1
month P ¼ 0.000598192; 2 months P ¼ 0.0000443631;
4 months P ¼ 0.004381456; see Fig. 6A].
In addition to histological analysis of the middle ear fluid, we
analysed the cell types within the ear fluids by fluorescence-acti-
vated cell sorting analysis (FACS) (Fig. 6B). Two antibodies
were used for the study. Gr-1 recognizes granulocytes
(PMNs) andmonocytes; the other, F4/80, is amarker for macro-
phages. The results from the FACS analysis confirmed the
results obtained from the histological study. At 21DAB,
33.2% of cells were Gr-1 positive and only 1.71% of cells
Figure 2. Craniofacial defect of Tgif mutant mice. (A) Size comparison of a male Tgif/Tgif mutant (bottom) and a wild-type mouse (top). (B) X-ray analysis of
2-month-old skulls from homozygous (hom, Tgif/Tgif), heterozygous (het, Tgif/+) and wild-type (wt, +/+) mice. Lateral X-rays show the craniofacial defect of
the mutant mice. (C) Dorsoventral view of a 2-month-old wild-type mouse skull showing the measurements used in this study. Scale bar ¼ 2 cm. (D) Graphic
comparison of the ratio of the nasal bone length (NL) to the full dorsal length of the skull (FL) for each Tgif genotype. N, number of mice used in the measure-
ments from each genotype. Bars: standard error of mean. ∗P, 0.05. (E) Ventral view of the middle ear and dissected bulla showing the ET of 2-month-old
homozygous (hom) and wild-type (wt) mice. ET, Eustachian tube; solid double-ended arrows: length of the tube; open double-ended arrows: width of the
tube. (F) Dissected and stained skulls of wild-type and homozygous mutant 2-month-old mice. ET angle measurements are indicated by white lines. R, right
ear; L, left ear. (G) Mean length and width of wild-type (wt) and homozygous mutant (hom) ETs along with mean angle between the midline of the skull
and the bony part of the left and the right Eustachian tubes in wild-type and homozygous mutants. Bars: standard error of mean.
Human Molecular Genetics, 2013, Vol. 22, No. 13 2557









were F4/80 positive. Examination of ear fluids in histological
sections did not reveal other populations of cells such as lym-
phocytes so the .60% shortfall in stainable cells in the FACS
analysis is probably attributable to high proportion of apoptotic
(Fig. 5F inset) and necrotic cells. At 1 month, the ear fluids con-
tained few identifiable cells (Fig. 5J), and the percentage of cells
positive for Gr-1 (4.4%) and F4/80 (0.6%) were low (Fig. 6B).
The proportion of F4/80 positive cells by FACSwas significant-
ly lower at 1 month compared with 21 DAB (P ¼ 0.028). Al-
though there was a very large reduction in Gr-1 cells at 1
month compared with 21 DAB, this difference was not signifi-
cant. At 2 months, there were again more cells positive for Gr-1
(10.7%), but also more for F4/80 (2.3%), confirming the result
from the immunohistochemistry (Fig. 5O, Fig. 6B). The propor-
tion of F4/80 positive cells by FACS was significantly higher at
2 months compared with 1 month (P ¼ 0.026).
Tgif homozygous mice have mucous effusions and elevated
levels of cytokines in ear fluids
To study the type of the effusion in the middle ear of the
homozygote mice, we looked for the expression of matrix
metalloproteinase-2 (MMP-2). The expression profile of
MMPs has been found to be specific to the type of middle
ear effusion (33), with the active form of MMP-2 only
found in mucous effusions of human patients with OM (33).
We looked for the expression of MMP-2 using western blot
and gelatine zymography and detected both pro- and active
MMP-2 in ear effusions of 2-month-old homozygote mice
(Fig. 7A and B). The zymography demonstrated high levels
of MMP-9 as well, which is specific to mucous effusions
(33). The result suggested that the homozygote mice have a
mucous-type ear effusion at 2 months.
This result was also confirmed by histological analysis of
middle ears performed with a combined Alcian blue/Periodic
acid-Schiff staining method (AB-PAS). Goblet cells are epi-
thelial cells whose function is to secrete mucin that dissolves
in water to form mucus. We detected a high density of goblet
cells, stained in purple by AB-PAS, among other cells in the
epithelium of the middle ear cavity of Tgif homozygote
mice (Fig. 7C).
Vascular endothelial growth factor A (VEGF-A) is a
member of the vascular permeability factor/VEGF family of
cytokines that are critical for vasculogenesis and pathological
and physiologic angiogenesis. The low level of VEGF expres-
sion in normal tissues and the overexpression in pathological
angiogenesis are regulated by many factors, including
hypoxia (34). Occurrence of hypoxia and elevated levels of
the VEGF protein has recently been reported for Jeff and
Junbo mice (11). For this reason, we assessed the level of
VEGF protein in ear fluids, comparing it to serum levels.
VEGF protein was detected in all serum samples and there
was no significant difference between genotypes (Fig. 8A).
Levels are very similar to the previously reported concentra-
tion of VEGF in sera of Jeff heterozygote mice (78 pg/ml).
However, the level of the protein in ear fluids of Tgif homozy-
gote mice was significantly higher (between 356.7 and 25
923.1 pg/ml) and was detected in 8 samples out of 10 (2 of
the samples had levels below the detectable range). VEGF
protein levels in Tgif/Tgif ear effusions were 66.6-fold ele-
vated when compared with Tgif/Tgif serum (Fig. 8A),
similar to Jeff mice (74-fold), although less than Junbo mice
(335-fold) (11).
TNF-a and Il-1b are cytokines involved in mediating in-
flammatory reactions. In wild-type, heterozygote and homozy-
gote Tgif mice, TNF-a protein was detectable in all serum
samples (except one) in very low concentrations (n ¼ 28,
range 1.2–18.3 pg/ml). The average concentration of TNF-a
in serum of homozygote mice was found to be 5.8 pg/ml, het-
erozygote mice 5 pg/ml and wild-type mice 5.2 pg/ml. Ele-
vated concentrations of TNF-a were detected in ear fluids of
homozygote mice (n ¼ 11, range between 480.9 and
3425.6 pg/ml) that were 262-fold elevated when compared
with Tgif/Tgif serum (Fig. 8B). TNF-a levels are also highly
raised in the ear fluids of Jeff (50-fold) and Junbo mice
(78-fold).
Il-1b protein was detectable in all blood samples (n ¼ 28,
range 1.8–24.6 pg/ml) with no significant difference
between the genotypes and was also elevated (78-fold) in
the ear effusions of Tgif/Tgif homozygtoes (n ¼ 10, range
between 91.8 and 1748.7 pg/ml) (Fig. 8C). Il-1b levels are
raised in Jeff (3-fold) and Junbo mice (26-fold).
The mutation in Tgif affects the TGFb signalling pathway
in the epithelial cells of the middle ears
Finally, we proceeded to investigate the action of TGIF on
TGFb signalling in the epithelial cells of the mouse middle
ear at the time when Tgif mutant mice start to develop OM.
We performed immunohistochemical staining using TGIF,
pSmad2, p21 and PML antibodies on ear sections from
3-week-old mice. TGIF protein was localized in the nucleus
of middle ear cavity epithelial cells in wild-type ears, but as
expected not in homozygous mutant ears. Phosphorylated
Smad2 was also localized in the epithelial cells. We detected
a clear difference between the number of epithelial cells posi-
tive for the pSmad2 antibody in wild-type and homozygous
mutant middle ears (Fig. 9). We counted epithelial cells in
Figure 3. Deafness phenotype by ABR. ABR thresholds in the right ears of
2-month-old Tgif/Tgif homozygote (hom), Tgif/+ heterozygote (het) and wild-
type (wt) mice. n, number of mice in ABR testing for each genotype. Bars:
standard error of mean. ∗P , 0.05.
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eight mutant and four wild-type ears and found a significant
difference between the percentage of cells positive for
pSmad2 (P ¼ 0.00029036). In wild-type middle ear, activated
Smad2 was localized in 34.87% of the epithelial cells when
compared with 15.58% in the homozygous middle ear. We
also performed immunohistochemistry with a p21 antibody
to examine localization of p21 in wild-type and mutant
middle ear epithelial cells and, consistent with raised levels
of pSmad2, detected more cells positive for p21 and much
stronger staining in wild-type cells (Fig. 9). Finally, we exam-
ined labelling patterns of cPML, an activator of TGFb signal-
ling that is sequestered in the nucleus, by binding to TGIF. In
wild type, the bulk of the labelling was observed in the cyto-
plasm and was unaffected in the homozygous mutant. We con-
clude from these observations that TGIF induces
TGFb-mediated transcriptional regulation in the epithelial
cells of the mouse middle ear at time when the mutant mice
develop OM and that this regulation does not involve signifi-
cant changes in the distribution of the cPML activator protein.
DISCUSSION
Our study has identified the Tgif knockout mouse as a novel
model of OM, providing further insights into the genetic
basis for chronic OM. Tgif mutants have a craniofacial
defect and reduced hearing by weaning age. Mice homozy-
gous for Tgif do not have any obvious inner ear abnormalities,
but demonstrate raised auditory thresholds detected by ABR.
OM is the major cause of hearing impairment in Tgif homozy-
gotes. The histological analysis revealed that they develop OM
by 21 DAB. At that stage, inflammatory cells are detectable in
the middle ear cavity of the mutant mice. By 2 months, the in-
flammation had progressed to a chronic state accompanied by
a thickened middle ear epithelial lining and the presence of in-
flammatory cells and macrophages within the middle ear
space. The inflammatory cell populations varied over time,
and this may reflect episodes of bacterial infection and clear-
ance. ET angle and morphology in homozygote mutants was
normal ruling out ET dysfunction as a contributory factor to
the OM that develops. Whereas Tgif homozygotes demonstrate
a highly penetrant OM, our analysis of heterozygotes reveals
chronic OM, but at a markedly lower frequency. Thus, Tgif
is a semi-dominant mutation of OM.
Previously, we have identified Fbxo11 and Evi1 as the
genes underlying two other mouse models of OM: Jeff and
Junbo (5,6). Both of these models are also associated with
defects in the regulation of TGFb signalling. Jeff has a
chronic proliferative OM (9), and it was shown that Fbxo11
Figure 4. Normal bundle morphology of the hair cells. (A) Scanning electron micrographs showing hair cell morphology in the mid turn of the cochlea of wild-
type (on the left) and homozygous Tgiif/Tgif (on the right) mice at two magnifications, age 1 month. Three rows of OHCs and a row of IHCs are observed along
the length of the organ of Corti in both wild-type and mutant mice. Normal bundle morphology for both OHCs and IHCs is observed in wild-type and mutants.
Scale bars ¼ 10 mm for the top panel and 1 mm for other panels; OHC, outer hair cell; IHC, inner hair cell. (B) Histological analysis of the hair cells in wild-type
(left panels) and homozygous Tgif/Tgif (right panels) mice, aged 2 months. Scale bars ¼ 1 mm for the top panel and 100 mm for other panels; OHC, outer hair
cell; IHC, inner hair cell; OC, organ of Corti; SG, spiral ganglion, RM, Reissner’s membrane.
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affects TGFb signalling by regulating the levels of phosphoS-
mad2 in the epithelial cells of palatal shelves, eyelids and
airways of the lungs (7). Mice heterozygous for Evi1 have a
hearing loss due to chronic suppurative OM (6). Evi1 is a zinc-
finger protein, that represses TGFb signalling by interacting
with the MH2 domain of Smad3 (10). However, for the first
time, we have identified OM arising from a lesion in a
protein within the TGFb signalling pathway and directly
involved in its regulation and control.
Recently, the role of hypoxia and HIF-mediated VEGF has
been highlighted as playing a key role in the pathogenesis of
OM in the Junbo and Jeff mutants (11). Protein levels of
VEGF, as well as the inflammatory cytokines, modulators of
HIF-1a, are significantly elevated in middle ear fluids in the
Junbo and Jeff mutants. There is considerable cross-talk
between TGFb and HIF-1a pathways and, for example,
Smad3 and HIF-1a cooperate with TGFb to induce VEGF
expression (35,36). We might, therefore, expect TGFb
pathway mutants to impact upon the middle ear’s response
to the hypoxia that develops in chronic OM. It is striking,
therefore, that the elevation of protein titres of VEGF, IL-1b
and TNFa that were observed in the Junbo and Jeff mutants
are also found in the Tgif mutant. Overall, both the OM pheno-
type in Tgif, along with the molecular pathogenesis observed
in the middle ear, provide considerable support to the view
that defects in TGFb signalling may impact generally on sus-
ceptibility to chronic OM.
TGIF is implicated in the regulation of TGFb signalling
through a number of routes. Initially, it was found that TGIF
can inhibit the signalling pathway, but recently, there is evi-
dence that it can also induce the pathway. TGIF can repress
transcription by recruiting to SMAD2 a co-repressor contain-
ing HDACs (37), or alternatively carboxyl terminus binding
protein (38) to an activated Smad complex. TGIF may also
Figure 5. Middle ear histology in Tgif homozygous mice. Each group of panels consists of representative images (transverse sections) of the middle ears of homo-
zygous (Tgif/Tgif) and wild-type (+/+) mice at different time points. (A and B) Five DAB (mutants analysed n ¼ 8, controls analysed n ¼ 5); (C and D) 14 DAB
(mutants n ¼ 8, controls n ¼ 10); (E–H) 21 DAB (mutants n ¼ 6, controls n ¼ 16); (I–L) 1-month old (mutants n ¼ 11, controls n ¼ 7); (M–T) 2 months
old (mutants n ¼ 12, controls n ¼ 7); (U–X) 4 months old (mutants n ¼ 10, controls n ¼ 10). (F and G) enlarged views of E; (J and K) enlarged views of I;
(N and P) enlarged views of M; (R and S) enlarged views of Q; (V and W) enlarged views of U. (F) Inset viable and apoptotic PMNs. (O) Immunohistochemical
staining of a 2-month-old homozygous mouse ear section using an F4/80 antibody. Macrophages are indicated with an arrow. Where indicated, the thickness of
the epithelial lining is shown with a double arrow. The presence of cellular aggregates is indicated by an asterisk (P) and an inflamed polyp by an arrowhead
(V). A–E, I, M, Q, U scale bar ¼ 4 mm; F, J, N, O, R scale bar ¼ 100 mm; G, H, K, L, P, S, T, V, W, X scale bar ¼ 200 mm. Pie charts represent percentage of
homozygote mice from different time points with no effusion and with effusion in one or in both ears.
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inhibit TGF-b signalling by participating in the degradation of
Smad2. TGIF can bind to TI1UL, and this interaction allows
the ubiquitin ligase to target Smad2 for degradation (20). Re-
cently, it has been shown that TGIF may inhibit TGFb signal-
ling independent of its association with Smads. The inhibition
involves interaction with cPML in the nucleus, thereby, sup-
pressing the phosphorylation of Smad2 by the TGFb receptor
(19). The interaction between TGIF and cPML can be influ-
enced by PCTA as PCTA competes with cPML for binding
with TGIF and reverses the inhibitory activity of TGIF
(21,22). PCTA binding to TGIF causes the release of cPML
from the nucleus to the cytoplasm, where it binds to the
TGFb receptors and promotes the phosphorylation of
Smad2. Induction of PCTA can enhance the ability of TGFb
to induce expression of endogenous ADAM12 and p21, two
TGFb target genes. In addition, PCTA depletion suppresses
their expression and can also blunt the growth inhibitory
action of TGFb (21).
We have shown that TGIF is localized in the epithelial cells
of the middle ear of wild-type mice at the time when the Tgif
mutant begins to develop OM. Moreover, pSmad2 was also
localized in the same cells. In the Tgif homozygous mutant,
as expected there are no epithelial cells positive for TGIF
and significantly fewer cells positive for pSmad2. This sug-
gests that TGIF is regulating the TGFb signalling pathway
by promoting the phosphorylation of Smad2 in middle ear epi-
thelia. Indeed, consistent with this, we have observed down
regulation of the TGFb target gene, p21, in the homozygous
mutant. It is not clear that these effects in the mutant are
mediated by cPML as we have not observed any changes in
levels of cPML that would account for the observed down
regulation of p21 in the Tgif mutant. It is possible that
changes to TGFb pathway activity occur via another route
not involving PCTA and cPML.
In conclusion, the discovery of an OM mouse model with a
mutation in a gene regulating the TGFb signalling pathway
highlights the role of this pathway in the genetic predispos-
ition to OM. Indeed, two candidate gene studies (3,39)
have demonstrated that FBXO11, a regulator of TGFb signal-
ling, is significantly associated with chronic and recurrent
OM in three independent cohorts. Recently, a GWAS ana-
lysis of association with OM in the Western Australian Preg-
nancy Cohort (Raine) study has identified 32 regions with
significant evidence of association, and pathway analysis
demonstrated a connection between top candidates and the
TGFb pathway (40). The identification of the Tgif mutant
Figure 6. Thickened epithelial lining and cytology of Tgif homozygous middle
ears. (A) Measurements of mucosal thickness of the middle ears of homozy-
gous (hom, Tgif/Tgif) and wild-type (wt, +/+) mice at different stages: 21
DAB (mutant ears measured n ¼ 6, controls measured n ¼ 7); 1-month-old
(mutants n ¼ 6, controls n ¼ 6); 2 months old (mutants n ¼ 7, controls n ¼
7); 4 months old (mutants n ¼ 7, controls n ¼ 6). Five measurements of the
epithelial lining of each ear were taken at a spacing of 250 mm. (B) FACS ana-
lysis of the ear effusions of 21 DAB, 1- and 2-month-old mice. Two antibodies
were used: Gr1 that recognizes granulocytes (neutrophils and eosinophils) and
monocytes and F4/80 that recognizes macrophages. n, number of mice used in
the analysis for each time point. Bars: standard error of mean. ∗P, 0.05.
Figure 7. OM phenotype of the 2-month-old Tgif mutants. (A) Western blot
analysis of total protein from the ear fluid of a 2-month-old homozygous
(Tgif/Tgif) mouse before (1) and after (2) removing the albumin from the
sample. The blot was probed with a MMP-2 antibody that detected both
pro- and active forms of MMP-2. (B) Gelatine zymography demonstrating
enzyme activity of MMP-2 and MMP-9 in Tgif/Tgif ear effusions. (C) Histo-
logical images of middle ear sections stained with AB-PAS, showing
mucus-producing goblet cells, stained in pink, in the epithelium of the
middle ear cavity (arrow) of a homozygous (right panel) and a wild-type
(left panel) mouse. Scale bar ¼ 20 mm.
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provides support for the role of TGFb signalling and its
effects on responses to hypoxia in the chronically inflamed
middle ear. Moreover, it provides a new candidate gene to
explore the genetic contributions to chronic and recurrent
OM in the human population.
MATERIALS AND METHODS
Mice
Tgif mutant mice were imported from The Jackson Labora-
tory. They were backcrossed onto a C57BL/6J background
for at least eight generations. The colony was then maintained
on a C57BL/6J background and genotyped as previously
described (28). Mice of all three possible genotypes were pro-
duced by intercrossing heterozygous Tgif-deficient mice.
Histology
Mouse adult 5-, 13- and 21-day old; 1-, 2- and 4-month-old
heads from wild-type, heterozygote and homozygote Tgif
mice were fixed in 10% buffered formaldehyde, decalcified
in Kristensen’s fluid for 4r days and embedded in paraffin fol-
lowing routine procedures. Three-micrometre-thick sections
were obtained, de-paraffinized in xylene substitute and rehy-
drated via a graded ethanol. For morphological observations,
sections were stained with H&E stain. Goblet cells were iden-
tified by a combined AB-PAS staining method.
Clickbox
One-month- and two-month-old mice were tested for a hearing
defect using a clickbox (Institute of hearing Research, Not-
tingham, UK) that generates a brief 20 kHz soundburst at
90 dB SPL, for a presence or a lack of Preyer’s reflex as pre-
viously described (32).
ABR analysis
Two-month-old wild-type, heterozygote and homozygote
mice, at least 10 from each group, were used for this
hearing test. The mice were anaesthetized and placed in an
audiometric chamber. The acoustic stimuli were delivered to
the right ear, and the test was analysed as previously described
(32). After the test, the mice were sacrificed by overdose
of anaesthetic, the heads were skinned and used for further
analysis.
X-ray analysis
Radiography was performed using a Faxitron Mx-20 DC-4
specimen X-ray System. Image analysis program ImageJ
was used to conduct measurements of the 2-month-old
skulls. To study the craniofacial defect of the Tgif mutant
mice, we compared the ratio between the full dorsal length
of the skull and the dorsal length of the nasal bone of 10 wild-
type, heterozygote and homozygote mice.
Scanning electron microscopy
Inner ears, dissected from two 1-month-old wild-type, hetero-
zygote and homozygote mice, were fixed, washed and decalci-
fied as previously described (41). After the decalcification, the
Figure 8. Protein composition of middle ear fluids in Tgif mutant mice. Levels
of mouse VEGF (A), TNF-a (B) and IL-1b (C) in serum samples and ear fluid
from wild-type (wt, +/+), heterozygote (het, Tgif/+) and homozygote (hom,
Tgif/Tgif) mice determined by Quantikine Immunoassays. n, number of mice
used in the analysis from each genotype. 25% quartile, median and 75% quar-
tile are indicated on the box plots and the whiskers represent the data range.
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organ of Corti was exposed, the ears were dehydrated in
ethanol, dried, sputter coated with gold and then viewed on
a JEOL 6010 LV scanning electron microscope under high
vacuum conditions.
Western blot
Total protein was extracted from the ear effusions of
2-month-old Tgif homozygote mice. Briefly, the effusions
were collected in phosphate-buffered saline (PBS), containing
a cocktail of protease inhibitors (cOmplate mini, Roche), cen-
trifuged at 10 000g for 30 min at 48C. The albumin was
removed from the supernatants using Qproteome Murine
Albumin depletion kit (QIAGEN). The samples were sub-
jected to 4–12% SDS NuPAGE (Invitrogen) and immuno-
blotted onto nitrocellulose membrane (Invitrogen). The
antibody for MMP2 (Abcam) was used in 1:500 dilution.
ECL Plus (GE Healthcare) was used as detection system.
We have to repeat the western blotting with a new antibody!
Zymography
The enzyme activity of MMP-2 was assessed by zymography
using gelatine impregnated gels. Total protein from ear
effusion, prepared the same way as for the western blots, was
loaded onto 10% SDS PAGE gels containing gelatine (Invitro-
gen). After electrophoresis, the gels were incubated in 1X
ZymogramRenaturing Buffer (Invitrogen) for 30 min, followed
by two incubations in 1X Zymogram Developing Buffer (Invi-
trogen)— the first one for 30 min at room temperature and the
second overnight at 378C. The gels were stained with Simply-
Blue Safestain (Invitrogen) and destained in water.
Blood and ear effusion collection for Vegf, TNF-a
and Il-1b protein assays
Blood from 8–10 wild-type, heterozygote and homozygote
mice was collected into serum-gel clotting activator tubes
(Sarstedt) from the retro-orbital sinus of mice under terminal
anaesthesia. The samples were left to clot for 2 h at room tem-
perature before centrifuging for 20 min at 2000g. The serum
was removed, aliquoted and stored at 2208C until required.
Measured volumes of ear fluids from 10 homozygote mice
were transferred in cold PBS, vortexed and centrifuged for
10 min at 500g, 48C. Supernatant ear fluids were stored at
2808C until required.
Quantikine mouse VEGF, IL-1b and TNF-a ELISA kits
(R&D System) were used to compare the levels of these
Figure 9. Protein expression in middle ear epithelia in Tgif mutant mice. (A) Immunohistochemistry of middle ear sections of wild-type (wt, +/+) and homo-
zygous (hom, Tgif/Tgif) mice, age 21 days after birth, stained with TGIF, phosphoSmad2 and p21 and cPML antibodies. Arrows indicate nuclear localization in
the epithelial cells. cPML was localized in the cytoplasm of the cells. No difference in the localization between wild-type and homozygous cells was observed
with the cPML antibody. MEC, middle ear cavity. Scale bars ¼ 1 mm and 20 mm. (B) Graphic comparison of the percentage of epithelial cells in the middle ear
positive for pSmad2. Bars: standard error of mean. ∗P , 0.05.
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three cytokines in the blood and ear fluid of the Tgif mutant
mice.
Ear effusion collection for FACS analysis
Ear effusions from homozygote mice of age 21 DAB, 1 and 2
months were collected in 100 ml cold FACS buffer (1% BSA
in PBS) and half of the amount was processed for the analysis.
The samples were washed, blocked and incubated with a
mixture of the two antibodies Gr1 (PerCP-Cy 5.5 Rat anti-
mouse Ly6G and Ly-6C, BD Pharminogen) and F4/80 (Rat
anti mouse mAb APC conjugated, Invitrogen) in 1:400 dilu-
tion for 20 min. After washing, the samples were processed
on BD FACS Cantoll and set to acquire 20 000 events in
FSC versus SSC gate with a flow rate of 0.5–1 ml/s.
Immunohistochemistry
For immunohistochemical analysis, the avidin–biotin complex
(ABC) method was used to look for the localization of Tgif,
pSmad2 and p21 in wild-type and mutant mouse middle ears.
The sections through the ears of the 3-week-old mice were
de-paraffinized, and endogenous peroxidase activity was
quenched with 3% hydrogen peroxide in isopropanol for
20 min. Vectastain Elite ABC kit (Vector Laboratories, PK
6101) was used to perform the immunohistochemistry. The
antibodies were as follows: rabbit polyclonal TGIF (H-172;
sc-9084 Santa Cruz Biotechnology), rabbit polyclonal
anti-phospho-Smad2 (Ser465/467) (AB3849 Chemicon Inter-
national) and rabbit polyclonal p21 (C-19; sc-397 Santa Cruz
Biotechnology). The sections were incubated with the anti-
bodies in 1:200 dilutions over night at 48C. DAB+ chromogen
system (DAKO K3468) was used to develop the specific
signals. The slides were counterstained with haematoxylin.
Data analysis
We used the Chi-squared test to compare the difference
between the observed and the expected number of the
mutant mice from crosses and Fisher’s exact tests to test pro-
portions of genotypes. To evaluate the probability of the cal-
culated Chi-squared value, the CHIDIST function in Excel
was used. Two-tailed t-test was used for comparing mean
ABR and FACS thresholds. A value of P , 0.05 was consid-
ered significant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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